Paper1376331
Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.
Felding-Habermann B and 3 others. J Clin Invest, 1992. Cited by 367 papers, by iCite.
Cite this record
ConductScience Library. Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. Papers, record 1376331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1376331
- Cell line
- M217 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Connected records4
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Integrins | Major topic |
| Melanoma | Major topic |
| Receptors, Immunologic | Major topic |
| Cell Division | |
| Gene Expression | |
| Glycoproteins | |
| Humans | |
| Kinetics | |
| Neoplasm Invasiveness | |
| Precipitin Tests | |
| Receptors, Vitronectin | |
| Transfection | |
| Tumor Cells, Cultured | |
| Vitronectin |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA45726 | NCI NIH HHS | United States | R01CA045726 | PubMed and NIH |
Source NIH RePORTER
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1690718 | The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. | J Biol Chem | 1990 | https://conductscience.org/library/papers/1690718 | PubMed |
| 2 | 6947225 | Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6947225 | PubMed |
| 3 | 2011740 | In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. | Science | 1991 | https://conductscience.org/library/papers/2011740 | PubMed |
| 4 | 2155708 | Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. | Cell | 1990 | https://conductscience.org/library/papers/2155708 | PubMed |
| 5 | 2447074 | Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. | J Biol Chem | 1987 | https://conductscience.org/library/papers/2447074 | PubMed |
| 6 | 2521461 | Changes in integrin receptors on oncogenically transformed cells. | Cell | 1989 | https://conductscience.org/library/papers/2521461 | PubMed |
| 7 | 3343338 | Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3343338 | PubMed |
| 8 | 3860849 | Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3860849 | PubMed |
| 9 | 6363104 | Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity. | Exp Cell Res | 1984 | https://conductscience.org/library/papers/6363104 | PubMed |
| 10 | 2821619 | New perspectives in cell adhesion: RGD and integrins. | Science | 1987 | https://conductscience.org/library/papers/2821619 | PubMed |
| 11 | 1691191 | The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. | J Cell Biol | 1990 | https://conductscience.org/library/papers/1691191 | PubMed |
| 12 | 1698118 | Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. | Cancer Res | 1990 | https://conductscience.org/library/papers/1698118 | PubMed |
| 13 | 1709170 | Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. | J Cell Biol | 1991 | https://conductscience.org/library/papers/1709170 | PubMed |
| 14 | 2138612 | A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). | J Biol Chem | 1990 | https://conductscience.org/library/papers/2138612 | PubMed |
| 15 | 2208139 | Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. | Cancer Res | 1990 | https://conductscience.org/library/papers/2208139 | PubMed |
| 16 | 2450560 | Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. | Biochemistry | 1987 | https://conductscience.org/library/papers/2450560 | PubMed |
| 17 | 2467745 | A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. | Cell | 1989 | https://conductscience.org/library/papers/2467745 | PubMed |
| 18 | 2752160 | A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. | Blood | 1989 | https://conductscience.org/library/papers/2752160 | PubMed |
| 19 | 2930685 | The inhibition of murine lung metastasis by synthetic polypeptides [poly(arg-gly-asp) and poly(tyr-ile-gly-ser-arg)] with a core sequence of cell adhesion molecules. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2930685 | PubMed |
| 20 | 3028640 | Integrins: a family of cell surface receptors. | Cell | 1987 | https://conductscience.org/library/papers/3028640 | PubMed |
Cited by129
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 367 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40892758 | A cytotoxic peptide-drug conjugate for tumor-specific delivery of co-injected molecules. | PLoS One | 2025 | https://conductscience.org/library/papers/40892758 | PubMed |
| 38534932 | ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma. | Curr Oncol | 2024 | https://conductscience.org/library/papers/38534932 | PubMed |
| 36920197 | Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins. | J Am Chem Soc | 2023 | https://conductscience.org/library/papers/36920197 | PubMed |
| 36892810 | Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers. | Adv Ther | 2023 | https://conductscience.org/library/papers/36892810 | PubMed |
| 34924562 | Signal pathways of melanoma and targeted therapy. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34924562 | PubMed |
| 34709754 | Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma. | Clin Transl Med | 2021 | https://conductscience.org/library/papers/34709754 | PubMed |
| 32955139 | Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. | Chemistry | 2021 | https://conductscience.org/library/papers/32955139 | PubMed |
| 32157692 | The role of integrins in melanoma: a review. | Int J Dermatol | 2020 | https://conductscience.org/library/papers/32157692 | PubMed |
| 31943410 | Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. | Chemistry | 2020 | https://conductscience.org/library/papers/31943410 | PubMed |
| 31322253 | Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma. | Oncol Rep | 2019 | https://conductscience.org/library/papers/31322253 | PubMed |
| 31275795 | Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. | ChemistryOpen | 2019 | https://conductscience.org/library/papers/31275795 | PubMed |
| 30939768 | Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/30939768 | PubMed |
| 28791115 | A cooperative polymeric platform for tumor-targeted drug delivery. | Chem Sci | 2016 | https://conductscience.org/library/papers/28791115 | PubMed |
| 28652358 | Targeting cancer cell integrins using gold nanorods in photothermal therapy inhibits migration through affecting cytoskeletal proteins. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28652358 | PubMed |
| 28357420 | SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growth. | Chem Commun (Camb) | 2017 | https://conductscience.org/library/papers/28357420 | PubMed |
| 27641750 | Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion. | Toxicon | 2016 | https://conductscience.org/library/papers/27641750 | PubMed |
| 27105671 | Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): A second aspartate amino acid carboxyl to the RGD in r-Moj-D_ peptides is not sufficient to induce apoptosis of SK-Mel-28 cells. | Toxicon | 2016 | https://conductscience.org/library/papers/27105671 | PubMed |
| 27063403 | Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. | Pharmacol Ther | 2016 | https://conductscience.org/library/papers/27063403 | PubMed |
| 25870133 | Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent. | Bioorg Med Chem Lett | 2015 | https://conductscience.org/library/papers/25870133 | PubMed |
| 25594011 | Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1. | Oncoscience | 2014 | https://conductscience.org/library/papers/25594011 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ITGAV | 3685 | PubTator's text mining | https://conductscience.org/library/genes/3685 | NCBI Gene |
| ITGB1 | 3688 | PubTator's text mining | https://conductscience.org/library/genes/3688 | NCBI Gene |
| VTN | 7448 | PubTator's text mining | https://conductscience.org/library/genes/7448 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1376331
GET https://conductscience.org/api/papers/v1/1376331/references?page=2